Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;18(9):538-541.

Vaccination Updates for Patients With Inflammatory Bowel Disease

Francis A Farraye  1
Affiliations

Vaccination Updates for Patients With Inflammatory Bowel Disease

Francis A Farraye. Gastroenterol Hepatol (N Y). 2022 Sep.
No abstract available

PubMed Disclaimer

References

    1. Anderson TC, Masters NB, Guo A et al. Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(3):80–84. - PMC - PubMed
    1. Crosby S, Schuh MJ, Becker M, Ivanov M, Caldera F, Farraye FA. New pneumococcal vaccines for prevention of invasive pneumococcal disease in adult patients with inflammatory bowel disease [published online July 13, 2022]. Inflamm Bowel Dis. doi:10.1093/ibd/izac150. - PubMed
    1. Desalermos A, Pimienta M, Kalligeros M Safety of immunizations for the adult patient with inflammatory bowel disease—a systematic review and meta-analysis [published online November 24, 2021]. Inflamm Bowel Dis. doi:10.1093/ibd/izab266. - PubMed
    1. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112(2):241–258. - PubMed
    1. Khan N, Wang L, Trivedi C et al. Efficacy of recombinant zoster vaccine in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2022;20(7):1570–1578.e1.. - PubMed

LinkOut - more resources